{"id":343677,"date":"2026-11-11T11:16:30","date_gmt":"2026-11-11T05:46:30","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=343677"},"modified":"2026-11-11T11:16:30","modified_gmt":"2026-11-11T05:46:30","slug":"pharmaceutical-formulations-company-crop-protection-chemicals-company-and-laminated-tubes-packaging-maker-stocks-roadmap-foothill-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/pharmaceutical-formulations-company-crop-protection-chemicals-company-and-laminated-tubes-packaging-maker-stocks-roadmap-foothill-list\/","title":{"rendered":"3 Pharmaceutical Formulations Company, Crop Protection Chemicals Company and Laminated Tubes Packaging Maker Stocks With a Strong Future Roadmap: Alembic Pharmaceuticals, Sharda Cropchem and EPL"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E84;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Alembic Pharmaceuticals, Sharda Cropchem and EPL: ROE of 11.9% to 21.7% and FY22 to FY26 revenue CAGR of 8.4% to 10.7%. Prices as of 10 Nov 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E84;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">The three generic pharma, crop care and tube stocks to watch are Alembic Pharmaceuticals, Sharda Cropchem and EPL. Their return on equity ranges from 11.9% to 21.7%, and their revenue compound annual growth from FY22 to FY26 ranges from 8.4% to 10.7%. Sharda Cropchem leads on both return on equity at 21.7% and revenue growth at 10.7% a year. Prices are based on the 10 November 2026 close, and this article is educational, not investment advice.<\/p>\n<\/div>\n<p>Generic pharma, crop care and tube stocks give investors a way to track businesses that sit close to everyday demand in India. Alembic Pharmaceuticals, Sharda Cropchem and EPL cover a pharmaceutical formulations company, a crop protection chemicals company and a laminated tubes packaging maker.<\/p>\n<p>This list covers three generic pharma, crop care and tube stocks with complete current figures: Alembic Pharmaceuticals, Sharda Cropchem and EPL. Every figure comes from the latest reported financials and the 10 November 2026 market close. Companies without complete current figures were left out.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=pharmaceutical-formulations-company-crop-protection-chemicals-company-and-laminated-tubes-packaging-maker-stocks-roadmap-foothill-list\">Click Here &#8211; Get Free Investment Predictions<\/a><\/strong><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceutical-formulations-company-crop-protection-chemicals-company-and-laminated-tubes-packaging-maker-stocks-roadmap-foothill-list\/#What_Are_Generic_Pharma_Crop_Care_and_Tube_Stocks\" title=\"What Are Generic Pharma, Crop Care and Tube Stocks?\">What Are Generic Pharma, Crop Care and Tube Stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceutical-formulations-company-crop-protection-chemicals-company-and-laminated-tubes-packaging-maker-stocks-roadmap-foothill-list\/#Generic_Pharma_Crop_Care_and_Tube_Stocks_at_a_Glance\" title=\"Generic Pharma, Crop Care and Tube Stocks at a Glance\">Generic Pharma, Crop Care and Tube Stocks at a Glance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceutical-formulations-company-crop-protection-chemicals-company-and-laminated-tubes-packaging-maker-stocks-roadmap-foothill-list\/#Why_Do_Generic_Pharma_Crop_Care_and_Tube_Stocks_Have_a_Strong_Roadmap_in_India\" title=\"Why Do Generic Pharma, Crop Care and Tube Stocks Have a Strong Roadmap in India?\">Why Do Generic Pharma, Crop Care and Tube Stocks Have a Strong Roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceutical-formulations-company-crop-protection-chemicals-company-and-laminated-tubes-packaging-maker-stocks-roadmap-foothill-list\/#Why_Alembic_Pharmaceuticals_Features_Among_These_Generic_Pharma_Crop_Care_and_Tube_Stocks\" title=\"Why Alembic Pharmaceuticals Features Among These Generic Pharma, Crop Care and Tube Stocks\">Why Alembic Pharmaceuticals Features Among These Generic Pharma, Crop Care and Tube Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceutical-formulations-company-crop-protection-chemicals-company-and-laminated-tubes-packaging-maker-stocks-roadmap-foothill-list\/#Why_Sharda_Cropchem_Features_Among_These_Generic_Pharma_Crop_Care_and_Tube_Stocks\" title=\"Why Sharda Cropchem Features Among These Generic Pharma, Crop Care and Tube Stocks\">Why Sharda Cropchem Features Among These Generic Pharma, Crop Care and Tube Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceutical-formulations-company-crop-protection-chemicals-company-and-laminated-tubes-packaging-maker-stocks-roadmap-foothill-list\/#Why_EPL_Features_Among_These_Generic_Pharma_Crop_Care_and_Tube_Stocks\" title=\"Why EPL Features Among These Generic Pharma, Crop Care and Tube Stocks\">Why EPL Features Among These Generic Pharma, Crop Care and Tube Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceutical-formulations-company-crop-protection-chemicals-company-and-laminated-tubes-packaging-maker-stocks-roadmap-foothill-list\/#Alembic_Pharmaceuticals_vs_Sharda_Cropchem_vs_EPL_on_Key_Financials\" title=\"Alembic Pharmaceuticals vs Sharda Cropchem vs EPL on Key Financials\">Alembic Pharmaceuticals vs Sharda Cropchem vs EPL on Key Financials<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceutical-formulations-company-crop-protection-chemicals-company-and-laminated-tubes-packaging-maker-stocks-roadmap-foothill-list\/#Key_Risks_to_Check_Before_Investing_in_Generic_Pharma_Crop_Care_and_Tube_Stocks\" title=\"Key Risks to Check Before Investing in Generic Pharma, Crop Care and Tube Stocks\">Key Risks to Check Before Investing in Generic Pharma, Crop Care and Tube Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceutical-formulations-company-crop-protection-chemicals-company-and-laminated-tubes-packaging-maker-stocks-roadmap-foothill-list\/#Final_Thoughts_on_Generic_Pharma_Crop_Care_and_Tube_Stocks\" title=\"Final Thoughts on Generic Pharma, Crop Care and Tube Stocks\">Final Thoughts on Generic Pharma, Crop Care and Tube Stocks<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceutical-formulations-company-crop-protection-chemicals-company-and-laminated-tubes-packaging-maker-stocks-roadmap-foothill-list\/#What_are_generic_pharma_crop_care_and_tube_stocks\" title=\"What are generic pharma, crop care and tube stocks?\">What are generic pharma, crop care and tube stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceutical-formulations-company-crop-protection-chemicals-company-and-laminated-tubes-packaging-maker-stocks-roadmap-foothill-list\/#Which_generic_pharma_crop_care_and_tube_stocks_are_covered_in_this_list\" title=\"Which generic pharma, crop care and tube stocks are covered in this list?\">Which generic pharma, crop care and tube stocks are covered in this list?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceutical-formulations-company-crop-protection-chemicals-company-and-laminated-tubes-packaging-maker-stocks-roadmap-foothill-list\/#Why_do_generic_pharma_crop_care_and_tube_stocks_have_a_strong_future_roadmap_in_India\" title=\"Why do generic pharma, crop care and tube stocks have a strong future roadmap in India?\">Why do generic pharma, crop care and tube stocks have a strong future roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceutical-formulations-company-crop-protection-chemicals-company-and-laminated-tubes-packaging-maker-stocks-roadmap-foothill-list\/#How_has_Alembic_Pharmaceuticals_performed_financially\" title=\"How has Alembic Pharmaceuticals performed financially?\">How has Alembic Pharmaceuticals performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceutical-formulations-company-crop-protection-chemicals-company-and-laminated-tubes-packaging-maker-stocks-roadmap-foothill-list\/#How_has_Sharda_Cropchem_performed_financially\" title=\"How has Sharda Cropchem performed financially?\">How has Sharda Cropchem performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceutical-formulations-company-crop-protection-chemicals-company-and-laminated-tubes-packaging-maker-stocks-roadmap-foothill-list\/#How_has_EPL_performed_financially\" title=\"How has EPL performed financially?\">How has EPL performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceutical-formulations-company-crop-protection-chemicals-company-and-laminated-tubes-packaging-maker-stocks-roadmap-foothill-list\/#What_risks_should_investors_check_before_buying_generic_pharma_crop_care_and_tube_stocks\" title=\"What risks should investors check before buying generic pharma, crop care and tube stocks?\">What risks should investors check before buying generic pharma, crop care and tube stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceutical-formulations-company-crop-protection-chemicals-company-and-laminated-tubes-packaging-maker-stocks-roadmap-foothill-list\/#Is_this_list_of_generic_pharma_crop_care_and_tube_stocks_investment_advice\" title=\"Is this list of generic pharma, crop care and tube stocks investment advice?\">Is this list of generic pharma, crop care and tube stocks investment advice?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_Generic_Pharma_Crop_Care_and_Tube_Stocks\"><\/span><strong>What Are Generic Pharma, Crop Care and Tube Stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Generic pharma, crop care and tube stocks are listed companies that develop and sell generic and specialty medicines, supply crop protection chemicals to farmers across many countries, and make laminated tubes and packaging for oral care, beauty and pharma brands. Their earnings depend on prescription demand, farm seasons and packaged goods volumes.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Generic_Pharma_Crop_Care_and_Tube_Stocks_at_a_Glance\"><\/span><strong>Generic Pharma, Crop Care and Tube Stocks at a Glance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">CMP (Rs)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Industry P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">ROE (%)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">D\/E<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/aplltd\/alembic-pharmaceuticals-ltd-share-price-today\">Alembic Pharmaceuticals<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,017.3<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">14,914<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">21.6<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">35.7<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">11.9<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.25<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/shardacrop\/sharda-cropchem-ltd-share-price-today\">Sharda Cropchem<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">690.5<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">6,314<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">10.1<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">23.3<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">21.7<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.00<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/epl\/epl-ltd-share-price-today\">EPL<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">224.41<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">7,244<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">18.4<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">21.7<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">13.6<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.34<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>On valuation, all three trade at a P\/E below their industry P\/E, which means the market is pricing them at a lower multiple than their peer group. Readers comparing generic pharma, crop care and tube stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain. With the Q2 FY27 results season close, investors in generic pharma, crop care and tube stocks can use the coming numbers to test whether growth is holding.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Do_Generic_Pharma_Crop_Care_and_Tube_Stocks_Have_a_Strong_Roadmap_in_India\"><\/span><strong>Why Do Generic Pharma, Crop Care and Tube Stocks Have a Strong Roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Generic pharma, crop care and tube stocks have a strong roadmap in India because steady global demand for medicines, wider use of crop protection and growing sales of branded personal care products keep widening the market for these companies.<\/p>\n<ul>\n<li><strong>Pharma.<\/strong> Doctors prescribe generic and specialty medicines.<\/li>\n<li><strong>Crop chemicals.<\/strong> Farmers protect crops across many countries.<\/li>\n<li><strong>Packaging.<\/strong> Brands need safe and attractive tubes.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Why_Alembic_Pharmaceuticals_Features_Among_These_Generic_Pharma_Crop_Care_and_Tube_Stocks\"><\/span><strong>Why Alembic Pharmaceuticals Features Among These Generic Pharma, Crop Care and Tube Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the generic pharma, crop care and tube stocks on this list, Alembic Pharmaceuticals is a Vadodara-based drug maker that sells generic formulations in the United States, branded medicines in India and active ingredients to other manufacturers.<\/p>\n<p>The company has a return on equity of 11.9%, a debt to equity ratio of 0.25 and a market capitalisation of Rs 14,914 crore. The stock trades at a P\/E of 21.6, below the industry P\/E of 35.7.<\/p>\n<p>Revenue rose from Rs 5,356 crore in FY22 to Rs 7,399 crore in FY26, a compound annual growth rate of 8.4%. Net profit grew from Rs 521 crore in FY22 to Rs 671 crore in FY26, which works out to a compound annual growth rate of 6.5%. In the June 2026 quarter, revenue grew 26.1% year on year to Rs 2,165 crore, while net profit rose 12.2% to Rs 172 crore.<\/p>\n<p><strong>Roadmap:<\/strong> The company is moving into complex generics such as injectables and ophthalmic products, which tend to face less competition. Steady growth in the India branded business adds stability.<\/p>\n<p><strong>What to watch:<\/strong> Follow new approvals in the United States, the pace of complex generic launches and domestic growth.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Sharda_Cropchem_Features_Among_These_Generic_Pharma_Crop_Care_and_Tube_Stocks\"><\/span><strong>Why Sharda Cropchem Features Among These Generic Pharma, Crop Care and Tube Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the medicine maker, crop protection and packaging shares on this list, Sharda Cropchem is a Mumbai-based agrochemical company that registers and sells crop protection products in Europe, Latin America, North America and other regions, along with non-agro chemicals.<\/p>\n<p>Revenue rose from Rs 3,609 crore in FY22 to Rs 5,410 crore in FY26, a compound annual growth rate of 10.7%. Net profit grew from Rs 349 crore in FY22 to Rs 681 crore in FY26, which works out to a compound annual growth rate of 18.2%.<\/p>\n<p>In the June 2026 quarter, revenue grew 8.9% year on year to Rs 1,108 crore. The company has a return on equity of 21.7%, a debt to equity ratio of 0.00 and a market capitalisation of Rs 6,314 crore. The stock trades at a P\/E of 10.1, below the industry P\/E of 23.3.<\/p>\n<p><strong>Roadmap:<\/strong> The company holds a large portfolio of product registrations in regulated markets, which is a barrier for new entrants. It sells through a lean, asset-light model, and carries no debt.<\/p>\n<p><strong>What to watch:<\/strong> Monitor the revenue mix of new registrations and the trend in global agrochemical prices.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_EPL_Features_Among_These_Generic_Pharma_Crop_Care_and_Tube_Stocks\"><\/span><strong>Why EPL Features Among These Generic Pharma, Crop Care and Tube Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the three companies on this list, EPL is among the world&#8217;s largest makers of laminated plastic tubes used for toothpaste, beauty, personal care and pharmaceutical products. It operates plants across Asia, Europe, the Americas and Africa.<\/p>\n<p>In the June 2026 quarter, revenue grew 24.7% year on year to Rs 1,392 crore. Revenue rose from Rs 3,445 crore in FY22 to Rs 4,806 crore in FY26, a compound annual growth rate of 8.7%.<\/p>\n<p>Net profit grew from Rs 221 crore in FY22 to Rs 394 crore in FY26, which works out to a compound annual growth rate of 15.5%. The company has a return on equity of 13.6%, a debt to equity ratio of 0.34 and a market capitalisation of Rs 7,244 crore. The stock trades at a P\/E of 18.4, below the industry P\/E of 21.7.<\/p>\n<p><strong>Roadmap:<\/strong> The company is growing sustainable tube formats such as recyclable tubes, which global brands increasingly prefer. A wide plant network lets it serve large customers in many regions.<\/p>\n<p><strong>What to watch:<\/strong> Track the share of sustainable tubes in sales and volume growth in beauty and personal care.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Alembic_Pharmaceuticals_vs_Sharda_Cropchem_vs_EPL_on_Key_Financials\"><\/span><strong>Alembic Pharmaceuticals vs Sharda Cropchem vs EPL on Key Financials<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table below sets the three generic pharma, crop care and tube stocks side by side on revenue, profit and margin, using reported figures.<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY22 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Revenue CAGR (FY22-FY26)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Net Profit (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Net Margin<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Alembic Pharmaceuticals<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">5,356<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">7,399<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">8.4%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">671<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">9.1%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Sharda Cropchem<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">3,609<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">5,410<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">10.7%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">681<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">12.6%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">EPL<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">3,445<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">4,806<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">8.7%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">394<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">8.2%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>Sharda Cropchem posts the highest return on equity in this group at 21.7%. Alembic Pharmaceuticals has the largest FY26 revenue at Rs 7,399 crore, and Sharda Cropchem shows the fastest revenue growth with a 10.7% compound annual rate. A useful habit with generic pharma, crop care and tube stocks is to check each new quarterly result against the capacity plans the company described earlier.<\/p>\n<p>The June 2026 quarter, the latest reported, gives a fresh read on momentum:<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Q1 FY26 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Q1 FY27 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Year-on-Year Growth<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Alembic Pharmaceuticals<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,717<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">2,165<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">26.1%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Sharda Cropchem<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,017<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,108<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">8.9%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">EPL<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,116<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,392<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">24.7%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_to_Check_Before_Investing_in_Generic_Pharma_Crop_Care_and_Tube_Stocks\"><\/span><strong>Key Risks to Check Before Investing in Generic Pharma, Crop Care and Tube Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Every theme carries risks that deserve a check before any decision. For these generic pharma, crop care and tube stocks, the main points are: Long-term medicine maker, crop protection and packaging shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.<\/p>\n<ul>\n<li><strong>Pricing pressure.<\/strong> Generic prices can change by market.<\/li>\n<li><strong>Season and monsoon.<\/strong> Crop protection sales follow rain and pest cycles.<\/li>\n<li><strong>Raw material costs.<\/strong> Ingredient and packaging prices can move margins.<\/li>\n<\/ul>\n<p>Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/screeners\">Use the Univest Stock Screener<\/a><\/strong> to filter generic pharma, crop care and tube stocks by market capitalisation, P\/E, ROE and growth, and build your own shortlist.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Final_Thoughts_on_Generic_Pharma_Crop_Care_and_Tube_Stocks\"><\/span><strong>Final Thoughts on Generic Pharma, Crop Care and Tube Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Generic pharma, crop care and tube stocks work best when investors track growth, valuation and return on equity side by side. Alembic Pharmaceuticals, Sharda Cropchem and EPL each have a clear plan to grow. Based on the 10 November 2026 close, Alembic Pharmaceuticals trades at Rs 1,017.3, Sharda Cropchem at Rs 690.5 and EPL at Rs 224.41. Valuation matters as much as growth, so compare each company&#8217;s P\/E with its industry P\/E before adding any of these generic pharma, crop care and tube stocks to a watchlist.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track generic pharma, crop care and tube stocks, set price alerts and get research-backed stock ideas.<\/em><\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h3><span class=\"ez-toc-section\" id=\"What_are_generic_pharma_crop_care_and_tube_stocks\"><\/span><strong>What are generic pharma, crop care and tube stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Generic pharma, crop care and tube stocks are listed companies that develop and sell generic and specialty medicines, supply crop protection chemicals to farmers across many countries, and make laminated tubes and packaging for oral care, beauty and pharma brands. Their earnings depend on prescription demand, farm seasons and packaged goods volumes. This list looks at three of them, Alembic Pharmaceuticals, Sharda Cropchem and EPL, using reported FY22 to FY26 financials and the 10 November 2026 closing prices.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_generic_pharma_crop_care_and_tube_stocks_are_covered_in_this_list\"><\/span><strong>Which generic pharma, crop care and tube stocks are covered in this list?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> This list covers Alembic Pharmaceuticals, Sharda Cropchem and EPL. Based on the 10 November 2026 close, Alembic Pharmaceuticals traded at Rs 1,017.3, Sharda Cropchem at Rs 690.5 and EPL at Rs 224.41. Their return on equity ranges from 11.9% to 21.7%, and their revenue compound annual growth from FY22 to FY26 ranges from 8.4% to 10.7%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_do_generic_pharma_crop_care_and_tube_stocks_have_a_strong_future_roadmap_in_India\"><\/span><strong>Why do generic pharma, crop care and tube stocks have a strong future roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Generic pharma, crop care and tube stocks have a strong roadmap in India because steady global demand for medicines, wider use of crop protection and growing sales of branded personal care products keep widening the market for these companies. The main drivers are as follows. Pharma. Doctors prescribe generic and specialty medicines. Crop chemicals. Farmers protect crops across many countries. Packaging. Brands need safe and attractive tubes. Together these factors give the companies on this list a visible path for growth over the coming years.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Alembic_Pharmaceuticals_performed_financially\"><\/span><strong>How has Alembic Pharmaceuticals performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 5,356 crore in FY22 to Rs 7,399 crore in FY26, a compound annual growth rate of 8.4%. Net profit grew from Rs 521 crore in FY22 to Rs 671 crore in FY26, which works out to a compound annual growth rate of 6.5%. In the June 2026 quarter, revenue grew 26.1% year on year to Rs 2,165 crore, while net profit rose 12.2% to Rs 172 crore. The company has a return on equity of 11.9%, a debt to equity ratio of 0.25 and a market capitalisation of Rs 14,914 crore. The stock trades at a P\/E of 21.6, below the industry P\/E of 35.7. Looking ahead, the company is moving into complex generics such as injectables and ophthalmic products, which tend to face less competition. Steady growth in the India branded business adds stability.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Sharda_Cropchem_performed_financially\"><\/span><strong>How has Sharda Cropchem performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 3,609 crore in FY22 to Rs 5,410 crore in FY26, a compound annual growth rate of 10.7%. Net profit grew from Rs 349 crore in FY22 to Rs 681 crore in FY26, which works out to a compound annual growth rate of 18.2%. In the June 2026 quarter, revenue grew 8.9% year on year to Rs 1,108 crore. The company has a return on equity of 21.7%, a debt to equity ratio of 0.00 and a market capitalisation of Rs 6,314 crore. The stock trades at a P\/E of 10.1, below the industry P\/E of 23.3. Looking ahead, the company holds a large portfolio of product registrations in regulated markets, which is a barrier for new entrants. It sells through a lean, asset-light model, and carries no debt.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_EPL_performed_financially\"><\/span><strong>How has EPL performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 3,445 crore in FY22 to Rs 4,806 crore in FY26, a compound annual growth rate of 8.7%. Net profit grew from Rs 221 crore in FY22 to Rs 394 crore in FY26, which works out to a compound annual growth rate of 15.5%. In the June 2026 quarter, revenue grew 24.7% year on year to Rs 1,392 crore. The company has a return on equity of 13.6%, a debt to equity ratio of 0.34 and a market capitalisation of Rs 7,244 crore. The stock trades at a P\/E of 18.4, below the industry P\/E of 21.7. Looking ahead, the company is growing sustainable tube formats such as recyclable tubes, which global brands increasingly prefer. A wide plant network lets it serve large customers in many regions.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_risks_should_investors_check_before_buying_generic_pharma_crop_care_and_tube_stocks\"><\/span><strong>What risks should investors check before buying generic pharma, crop care and tube stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors should check a few risks before buying generic pharma, crop care and tube stocks. Pricing pressure. Generic prices can change by market. Season and monsoon. Crop protection sales follow rain and pest cycles. Raw material costs. Ingredient and packaging prices can move margins. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_this_list_of_generic_pharma_crop_care_and_tube_stocks_investment_advice\"><\/span><strong>Is this list of generic pharma, crop care and tube stocks investment advice?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No. This article is educational and uses publicly available data as of the 10 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What are generic pharma, crop care and tube stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Generic pharma, crop care and tube stocks are listed companies that develop and sell generic and specialty medicines, supply crop protection chemicals to farmers across many countries, and make laminated tubes and packaging for oral care, beauty and pharma brands. Their earnings depend on prescription demand, farm seasons and packaged goods volumes. This list looks at three of them, Alembic Pharmaceuticals, Sharda Cropchem and EPL, using reported FY22 to FY26 financials and the 10 November 2026 closing prices.\"}},{\"@type\":\"Question\",\"name\":\"Which generic pharma, crop care and tube stocks are covered in this list?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"This list covers Alembic Pharmaceuticals, Sharda Cropchem and EPL. Based on the 10 November 2026 close, Alembic Pharmaceuticals traded at Rs 1,017.3, Sharda Cropchem at Rs 690.5 and EPL at Rs 224.41. Their return on equity ranges from 11.9% to 21.7%, and their revenue compound annual growth from FY22 to FY26 ranges from 8.4% to 10.7%.\"}},{\"@type\":\"Question\",\"name\":\"Why do generic pharma, crop care and tube stocks have a strong future roadmap in India?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Generic pharma, crop care and tube stocks have a strong roadmap in India because steady global demand for medicines, wider use of crop protection and growing sales of branded personal care products keep widening the market for these companies. The main drivers are as follows. Pharma. Doctors prescribe generic and specialty medicines. Crop chemicals. Farmers protect crops across many countries. Packaging. Brands need safe and attractive tubes. Together these factors give the companies on this list a visible path for growth over the coming years.\"}},{\"@type\":\"Question\",\"name\":\"How has Alembic Pharmaceuticals performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 5,356 crore in FY22 to Rs 7,399 crore in FY26, a compound annual growth rate of 8.4%. Net profit grew from Rs 521 crore in FY22 to Rs 671 crore in FY26, which works out to a compound annual growth rate of 6.5%. In the June 2026 quarter, revenue grew 26.1% year on year to Rs 2,165 crore, while net profit rose 12.2% to Rs 172 crore. The company has a return on equity of 11.9%, a debt to equity ratio of 0.25 and a market capitalisation of Rs 14,914 crore. The stock trades at a P\/E of 21.6, below the industry P\/E of 35.7. Looking ahead, the company is moving into complex generics such as injectables and ophthalmic products, which tend to face less competition. Steady growth in the India branded business adds stability.\"}},{\"@type\":\"Question\",\"name\":\"How has Sharda Cropchem performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 3,609 crore in FY22 to Rs 5,410 crore in FY26, a compound annual growth rate of 10.7%. Net profit grew from Rs 349 crore in FY22 to Rs 681 crore in FY26, which works out to a compound annual growth rate of 18.2%. In the June 2026 quarter, revenue grew 8.9% year on year to Rs 1,108 crore. The company has a return on equity of 21.7%, a debt to equity ratio of 0.00 and a market capitalisation of Rs 6,314 crore. The stock trades at a P\/E of 10.1, below the industry P\/E of 23.3. Looking ahead, the company holds a large portfolio of product registrations in regulated markets, which is a barrier for new entrants. It sells through a lean, asset-light model, and carries no debt.\"}},{\"@type\":\"Question\",\"name\":\"How has EPL performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 3,445 crore in FY22 to Rs 4,806 crore in FY26, a compound annual growth rate of 8.7%. Net profit grew from Rs 221 crore in FY22 to Rs 394 crore in FY26, which works out to a compound annual growth rate of 15.5%. In the June 2026 quarter, revenue grew 24.7% year on year to Rs 1,392 crore. The company has a return on equity of 13.6%, a debt to equity ratio of 0.34 and a market capitalisation of Rs 7,244 crore. The stock trades at a P\/E of 18.4, below the industry P\/E of 21.7. Looking ahead, the company is growing sustainable tube formats such as recyclable tubes, which global brands increasingly prefer. A wide plant network lets it serve large customers in many regions.\"}},{\"@type\":\"Question\",\"name\":\"What risks should investors check before buying generic pharma, crop care and tube stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Investors should check a few risks before buying generic pharma, crop care and tube stocks. Pricing pressure. Generic prices can change by market. Season and monsoon. Crop protection sales follow rain and pest cycles. Raw material costs. Ingredient and packaging prices can move margins. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.\"}},{\"@type\":\"Question\",\"name\":\"Is this list of generic pharma, crop care and tube stocks investment advice?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No. This article is educational and uses publicly available data as of the 10 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Generic Pharma, Crop Care and Tube Stocks with a strong future roadmap: Alembic Pharmaceuticals, Sharda Cropchem and EPL. Compare price, valuation, return on equity and revenue growth as of 10 November 2026.<\/p>\n","protected":false},"author":28,"featured_media":343676,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[22155,10050,3803,22153,22154,9916,12372,22152,22053,6970],"class_list":["post-343677","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-agrochemical-and-toothpaste-tube-stocks","tag-alembic-pharmaceuticals","tag-best-stocks","tag-crop-care-and-tube-stocks","tag-crop-protection-and-packaging-shares","tag-epl","tag-formulation-maker","tag-generic-pharma","tag-medicine-maker","tag-sharda-cropchem"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["343676"],"rank_math_title":["Generic Pharma, Crop Chemical and Tube Packaging Stocks"],"rank_math_description":["Compare 3 generic pharma, crop care and tube stocks with a strong future roadmap on CMP, market cap, P\/E, ROE and revenue growth. Data as of 10 Nov 2026."],"rank_math_focus_keyword":["generic pharma, crop care and tube stocks"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/11\/3-pharmaceutical-formulations-company-crop-protection-chemicals-company-and.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/343677","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/28"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=343677"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/343677\/revisions"}],"predecessor-version":[{"id":343678,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/343677\/revisions\/343678"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/343676"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=343677"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=343677"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=343677"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}